Efficacy of Trans-spinal Magnetic Stimulation on Functional Mobility in Chronic Stroke Patients

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn if trans-spinal magnetic stimulation works to treat gait disorders in chronic stroke adults. It will also learn about the safety of trans-spinal magnetic stimulation. The main questions it aims to answer are: Does trans-spinal magnetic stimulation enhance chronic stroke participants gait and functional mobility? Does the technique cause any side effects? Researchers will compare trans-spinal magnetic stimulation to a sham (a look-alike stimulation with no real effect) to see if trans-spinal magnetic stimulation works to treat gait disorders and improve functional mobility. Participants will: Receive trans-spinal magnetic stimulation with treadmill training or a sham stimulation with treadmill training every day for 2 weeks.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Confirmation of Stroke by digital or physical imaging or medical report

• Gait impairment

• Stroke with at least 6 months after ictus

Locations
Other Locations
Brazil
Federal University of Paraiba
RECRUITING
João Pessoa
Federal University of Pernambuco
RECRUITING
Recife
Federal University of Rio de Janeiro
RECRUITING
Rio De Janeiro
Contact Information
Primary
Daniel G Melo, Physical Therapy
gmelodaniel@gmail.com
55 + 81995173332
Time Frame
Start Date: 2024-06-01
Estimated Completion Date: 2025-08-01
Participants
Target number of participants: 30
Treatments
Experimental: Active trans-spinal magnetic stimulation
Trans-spinal magnetic stimulation activates afferent spinal roots and increases cortical excitability.
Sham_comparator: Sham trans-spinal magnetic stimulation
Treadmill training with masking for trans-spinal magnetic stimulation
Related Therapeutic Areas
Sponsors
Leads: Universidade Federal de Pernambuco

This content was sourced from clinicaltrials.gov